Mokry J, Mokra D, Nosalova G, Beharkova M, Feherova Z
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:473-82.
As the administration of many antitussive drugs is often associated with adverse effects, new alternatives are evaluated in experimental and clinical conditions. The aim of this study was to assess the influence of selective inhibitors of PDE3 (cilostazol) and PDE4 (citalopram) on cough and airway reactivity. The number of cough efforts, specific airway resistance, in vitro airway reactivity, and differential blood cells count were measured in healthy and in ovalbumin-sensitized guinea pigs before and after administration of cilostazol or citalopram (1 mg/kg). Cilostazol significantly suppressed citric acid induced cough only in healthy guinea pigs, whereas citalopram in both healthy and ovalbumin-sensitized animals. Both PDE inhibitors decreased in vivo and in vitro airway reactivity to histamine and the count of monocytes and neutrophils, confirming their anti-inflammatory potential. Administration of selective PDE3 and PDE4 inhibitors may influence cough and airway reactivity in the model of ovalbumin-sensitized guinea pigs.
由于许多镇咳药物的使用常常伴随着不良反应,因此在实验和临床条件下对新的替代药物进行了评估。本研究的目的是评估磷酸二酯酶3(西洛他唑)和磷酸二酯酶4(西酞普兰)的选择性抑制剂对咳嗽和气道反应性的影响。在给予西洛他唑或西酞普兰(1毫克/千克)之前和之后,测量健康豚鼠和卵清蛋白致敏豚鼠的咳嗽次数、比气道阻力、体外气道反应性以及血细胞分类计数。西洛他唑仅在健康豚鼠中显著抑制柠檬酸诱导的咳嗽,而西酞普兰在健康和卵清蛋白致敏动物中均有此作用。两种磷酸二酯酶抑制剂均降低了体内和体外对组胺的气道反应性以及单核细胞和中性粒细胞的计数,证实了它们的抗炎潜力。选择性磷酸二酯酶3和磷酸二酯酶4抑制剂的给药可能会影响卵清蛋白致敏豚鼠模型中的咳嗽和气道反应性。